The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Transcatheter aortic valve implantation (TAVI) has risen over the past 20 years as a safe and
effective alternative to surgical aortic valve replacement for treatment of severe aortic …

Importance Aortic valve stenosis (AS) is the most common manifestation of acquired valvular
heart disease in developed countries. Several large-scale randomized clinical trials …

Background Valve-in-valve (VIV) transcatheter aortic valve replacement (TAVR) and redo
surgical aortic valve replacement (SAVR) represent the 2 treatments for aortic bioprosthesis …

Background The postoperative outcomes of transcatheter aortic valve replacement (TAVR)
with the new generation of self-expanding valves (SEV) and balloon-expandable valves …

Summary Background The Hospital Frailty Risk Score (HFRS) has been widely but
inconsistently applied in published studies, particularly in how diagnostic information …

Transcatheter aortic valve replacement (TAVR) has developed into an established therapy
for patients with severe aortic stenosis (AS) across the spectrum of surgical risk. Despite …

Aims Permanent pacemaker implantation (PPI) may be required after transcatheter aortic
valve implantation (TAVI). Evidence on PPI prediction has largely been gathered from high …

Background: Transcatheter aortic valve implantation (TAVI) is the preferred treatment for
symptomatic severe aortic stenosis (AS) in a majority of patients across all surgical risks …

Objectives To compare safety, efficacy, and hemodynamics of transfemoral transcatheter
aortic valve replacement (TAVR) using self‐expanding and balloon‐expandable …